IVOG:NYE-Vanguard S&P Mid-Cap 400 Growth Index Fund ETF Shares (USD)

ETF | Mid-Cap Growth |

Last Closing

USD 114.16

Change

0.00 (0.00)%

Market Cap

USD 1.09B

Volume

0.01M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The fund employs an indexing investment approach designed to track the performance of the index, which represents the growth companies, as determined by the index sponsor, of the S&P MidCap 400 Index. The advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-21 )

Largest Industry Peers for Mid-Cap Growth

ETFs Containing IVOG

N/A

Market Performance

  Market Performance vs. Industry/Classification (Mid-Cap Growth) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 16.22% 87% B+ 75% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 16.22% 80% B- 69% C-
Trailing 12 Months  
Capital Gain 27.11% 63% D 74% C
Dividend Return 1.25% 80% B- 17% F
Total Return 28.37% 69% C- 71% C-
Trailing 5 Years  
Capital Gain 62.06% 56% F 76% C+
Dividend Return 4.51% 79% B- 13% F
Total Return 66.56% 63% D 73% C
Average Annual (5 Year Horizon)  
Capital Gain 12.08% 56% F 73% C
Dividend Return 12.91% 56% F 70% C-
Total Return 0.83% 80% B- 18% F
Risk Return Profile  
Volatility (Standard Deviation) 22.93% 69% C- 45% F
Risk Adjusted Return 56.31% 69% C- 74% C
Market Capitalization 1.09B 67% D+ 58% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.